57.73% and what growth studies really measured

Two small studies first set rosemary oil against minoxidil 2%, and later projects added peptides, low dose oral minoxidil and regenerative care. That sequence came into focus with the June 2026 guide and a 90 day trial reported before 10 September 2026.

Panahi and coworkers assigned 100 people with androgenetic alopecia to rosemary oil or 2% minoxidil across six months in 2015. Hair counts climbed clearly from the start in each arm, with no meaningful gap between arms. Itching of the scalp appeared more often with minoxidil, at 44.4% compared with 15% for rosemary, and dandruff appeared more often with minoxidil, at 32.2% compared with 7.5% for rosemary.

Nasirian and coworkers assigned 60 volunteers to 2% rosemary oil or 2% minoxidil across 24 weeks in 2020. Counts grew by 10% with rosemary and by 13% with minoxidil, with p equals 0.12. The near result counts, yet the strength counts too. Those studies tested 2% minoxidil, not the stronger 5% product many adults apply, so similarity there does not show sameness with present standard dosing.

The latest rosemary result combined the plant with lavender and a control group. Patel and coworkers assigned 90 volunteers in 2025 to rosemary-lavender oil, a peptide blend or control across 90 days. With steady daily sectioning and massage the rosemary lavender group raised hair growth rate by 57.73% against control at p less than 0.0001. On that same routine the group raised thickness by 68.70% and density by about 32% against control, while shedding dropped by more than 40%.

Lab work points to one possible route for how it acts. Murata and coworkers reported in 2013 that rosemary leaf extract blocked 5-alpha reductase by 82.4% at 200 ug per mL and by 94.6% at 500 ug per mL in vitro. In that same test finasteride produced 81.9% inhibition. Activity in glass does not predict activity on skin in real use.

Peptides remain earlier in the evidence root system with less to guide use. In a phase 2A trial, the peptide PP405 woke up hair follicle stem cells and grew visibly more hair in eight weeks in 78 people. For 90 days, 45 people aged 18 to 45 years in a telogen effluvium study split into three groups of 15 and applied 2 mL once daily of Capilia longa blends, cytokine and peptide blends, or redensyl with aminexil. The groups run small, the check ins end soon and the formulas keep changing.

Low dose oral minoxidil is shifting from private clinic habit to shared routine. An international guide on starting it and tracking it took 4th place as a poster at the 2024 American Academy of Dermatology Annual Meeting. It listed daily amounts of 0.625 to 2.5 mg for adolescent females, 0.625 to 5 mg for adult females, and 1.25 to 5 mg for adolescent and adult males. You can usually judge if it is working between 3 to 6 months of steady use. That advice leans on expert agreement because bigger trials are still scarce. A meta analysis showed platelet rich plasma improved hair count and density measurably compared with controls. “Regenerative therapies like PRP have become an important part of how we treat early hair loss, since they use the body’s own healing signals,” said Dr. Lindsay Bordone, MD, FAAD, dermatologist at Columbia University and the American Academy of Dermatology.

For a slow routine at home, the tradeoff is plain. Rosemary asks for daily care and patience, with less itch in these trials but without proof of lasting gains after stopping. Talk with a dermatologist about shedding or thinning that worries you. We still do not know if store oils equal lab made preps or equal minoxidil 5 percent over 12 months.

Look for bigger trials that test plain 5 percent dosing, named peptide amounts and longer check ins.